출판: MarketsandMarkets（마켓츠앤드마켓츠）출판년월：2021년11월
・제품 (마이크로 매니퓰레이터, 인큐베이터, 캐비닛, 이미징 시스템, 레이저 시스템, 시약 및 액세서리), 유형 (종래 IVF, 현미경 수정으로 체외 수정), 최종 사용자 (불임 치료 클리닉, 병원, 정자 은행) – 2026 까지의 세계 예측
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026
| 폐이지수 | 234 |
| 도표수 | 259 |
| 구성 | 영문조사보고서 |
| 가격표 |
The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain extent.
COVID-19 pandemic triggered the worldwide suspension of in vitro fertilization treatment; this had a profound impact on women undergoing IVF procedures. In India, 30 lakh people seek IVF every year,
but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19
pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who had opted for IVF treatment before the pandemic
“The equipment to capture the largest share in in vitro fertilization market, by products during the forecast period.”
The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the increasing number of IVF procedures and introduction of highly advanced IVF equipment by well-established manufacturers in the market.
“The fresh non-donor segment to capture the largest market share of in vitro fertilization market, by the type of cycle in 2021.”
The fresh non-donor segment captured the largest share of the in vitro fertilization market cycles during the forecast period. High success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.
“The IVF with ICSI segment registered the highest growth rate of the in vitro fertilization market, by type, in 2021”
The IVF with ICSI segment registered the highest growth rate of the in vitro fertilization market. The success rate of fertilization with ICSI procedure, and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period.
“The fertility clinics segment accounted for the largest share of the in vitro fertilization market, by end user, in 2021”
The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, growing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.
“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The in vitro fertilization market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Rise in medical tourism, growing adoption of assisted reproductive technology, expansion of IVF fertility clinics in the region, increasing prevalence of polycystic ovarian disease (PCOD), improving healthcare expenditure on in vitro fertilization, and initiatives by the government to increase the accessibility of the in vitro fertilization treatment in the emerging nations.
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%
The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany).
Research Coverage
This report studies the global in vitro fertilization market based on the product, cycle, type, end users, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global in vitro fertilization market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
목차
1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY USED FOR THE STUDY 33
1.5 MAJOR MARKET STAKEHOLDERS 33
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Secondary sources 37
2.1.2 PRIMARY DATA 37
FIGURE 2 BREAKDOWN OF PRIMARIES: IN VITRO FERTILIZATION MARKET 38
2.2 MARKET ESTIMATION METHODOLOGY 38
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 39
2.2.2 USAGE -BASED MARKET ESTIMATION 40
FIGURE 4 MARKET SIZE ESTIMATION: IN VITRO FERTILIZATION MARKET BASED
ON PRODUCT UTILIZATION METHODOLOGY 40
FIGURE 5 MARKET SIZE ESTIMATION: IN VITRO FERTILIZATION MARKET BASED
ON REVENUE MAPPING METHODOLOGY 41
2.2.3 PRIMARY RESEARCH VALIDATION 41
2.3 DATA TRIANGULATION 42
FIGURE 6 DATA TRIANGULATION METHODOLOGY 42
2.4 RESEARCH ASSUMPTIONS 43
2.5 RESEARCH LIMITATIONS 43
3 EXECUTIVE SUMMARY 44
FIGURE 7 IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 44
FIGURE 8 IN VITRO FERTILIZATION MARKET, BY REAGENTS & MEDIA,
2021 VS. 2026 (USD MILLION) 45
FIGURE 9 IN VITRO FERTILIZATION MARKET, BY CYCLE, 2021 VS. 2026 (USD MILLION) 45
FIGURE 10 IN VITRO FERTILIZATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 46
FIGURE 11 IN VITRO FERTILIZATION MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 46
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE IN VITRO FERTILIZATION MARKET 47
4 PREMIUM INSIGHTS 48
4.1 IN VITRO FERTILIZATION MARKET OVERVIEW 48
FIGURE 13 DELAYED PREGNANCY IN WOMEN IS KEY GROWTH DRIVER OF IVF MARKET 48
4.2 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 49
FIGURE 14 REAGENTS AND MEDIA SEGMENT TO REGISTER HIGHEST GROWTH IN IN VITRO FERTILIZATION MARKET DURING FORECAST PERIOD 49
4.3 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2021 VS. 2026 (USD MILLION) 49
FIGURE 15 FRESH NON-DONOR SEGMENT HOLDS LARGEST SHARE
OF IN VITRO FERTILIZATION MARKET 49
4.4 IN VITRO FERTILIZATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 16 IVF WITH ICSI SEGMENT TO WITNESS HIGHEST GROWTH
IN FORECAST PERIOD 50
4.5 IN VITRO FERTILIZATION MARKET SHARE, BY END USER, 2021 50
FIGURE 17 FERTILITY CENTERS EXHIBIT LARGEST DEMAND FOR IN VITRO
FERTILIZATION PRODUCTS 50
4.6 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT AND COUNTRY (2021) 51
FIGURE 18 EQUIPMENT SEGMENT ACCOUNTED FOR LARGEST SHARE OF
IN VITRO FERTILIZATION MARKET IN APAC 51
FIGURE 19 APAC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST
PERIOD (2021–2026) 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 20 IVF MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Increase in median age of first-time mothers 54
5.2.1.2 Declining fertility rate 54
5.2.1.3 Rising number of fertility clinics worldwide 55
5.2.1.4 Male infertility on the rise 55
5.2.1.5 Growing rate of obesity and increased consumption of alcohol 56
5.2.1.6 Technological advancements and product innovation 56
5.2.1.6.1 Advancements in IVF devices 56
5.2.1.6.2 Growing use of time-lapse technology worldwide 57
5.2.1.7 Increasing public-private funding 57
5.2.1.8 Government initiatives to promote IVF treatments 58
5.2.2 RESTRAINTS 58
5.2.2.1 High costs associated with IVF procedures 58
TABLE 1 IVF COSTS 58
5.2.2.2 Restrictive regulations and ethical concerns 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growth opportunities in emerging markets 59
5.2.3.1.1 Increasing medical tourism 59
5.2.3.2 Use of fertility treatment options by single parents and
same-sex couples 60
5.2.4 CHALLENGES 60
5.2.4.1 Reducing efficacy of infertility treatment among patients
with advancing age 60
5.3 REGULATORY LANDSCAPE 61
5.3.1 NORTH AMERICA 61
5.3.1.1 US 61
5.3.1.2 Canada 62
5.3.2 EUROPE 62
5.3.3 ASIA PACIFIC 62
5.3.3.1 India 62
5.3.3.2 Japan 62
TABLE 2 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 63
5.4 COVID-19 IMPACT ON THE IVF MARKET 63
FIGURE 21 SIX-MONTH DELAY IN IVF – % REDUCTION IN LIVE BIRTHS IN 2020 64
FIGURE 22 12-MONTH DELAY IN IVF – % REDUCTION IN LIVE BIRTHS 64
5.5 VALUE CHAIN ANALYSIS 65
FIGURE 23 VALUE CHAIN OF THE IVF MARKET 65
5.6 PRICING TREND ANALYSIS 66
TABLE 3 AVERAGE PRICE OF IVF EQUIPMENT AND MEDIA, BY COUNTRY, 2020 (USD) 66
5.7 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 4 IVF MARKET: PORTER’S FIVE FORCES ANALYSIS 67
5.7.1 THREAT OF NEW ENTRANTS 67
FIGURE 24 THREAT OF NEW ENTRANTS 67
5.7.2 THREAT OF SUBSTITUTES 68
FIGURE 25 THREAT OF SUBSTITUTES 68
5.7.3 BARGAINING POWER OF SUPPLIERS 68
FIGURE 26 BARGAINING POWER OF SUPPLIERS 68
5.7.4 BARGAINING POWER OF BUYERS 69
FIGURE 27 BARGAINING POWER OF BUYERS 69
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
FIGURE 28 INTENSITY OF COMPETITIVE RIVALRY 70
5.8 ECOSYSTEM COVERAGE 70
6 IN VITRO FERTILIZATION MARKET, BY PRODUCT 71
6.1 INTRODUCTION 72
TABLE 5 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 72
6.2 EQUIPMENT 72
TABLE 6 IN VITRO FERTILIZATION MARKET, BY EQUIPMENT,
2019–2026 (USD MILLION) 73
TABLE 7 IN VITRO FERTILIZATION MARKET, BY REAGENTS & MEDIA
2019–2026 (USD MILLION) 73
TABLE 8 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY CYCLE,
2019–2026 (USD MILLION) 74
TABLE 9 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 74
TABLE 10 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 75
TABLE 11 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 75
6.2.1 IMAGING SYSTEMS 75
6.2.1.1 Increasing use during IVF procedures to drive market 75
TABLE 12 IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 76
TABLE 13 IMAGING SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 76
TABLE 14 IMAGING SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 77
TABLE 15 IMAGING SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 77
6.2.2 SPERM SEPARATION SYSTEMS 77
6.2.2.1 Wide range of applications in fertility procedures 77
TABLE 16 SPERM SEPARATION SYSTEM MARKET, BY REGION,
2019–2026 (USD MILLION) 78
TABLE 17 SPERM SEPARATION SYSTEM MARKET, BY CYCLE,
2019–2026 (USD MILLION) 78
TABLE 18 SPERM ANALAYZER SYSTEM MARKET, BY TYPE, 2019–2026 (USD MILLION) 79
TABLE 19 SPERM SEPARATION SYSTEM MARKET, BY END USER,
2019–2026 (USD MILLION) 79
6.2.3 OVUM ASPIRATION PUMPS 79
6.2.3.1 Facilitate retrieval and protection of oocytes 79
TABLE 20 OVUM ASPIRATION PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION) 80
TABLE 21 OVUM ASPIRATION PUMPS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 80
TABLE 22 OVUM ASPIRATION PUMPS MARKET, BY TYPE, 2019–2026 (USD MILLION) 81
TABLE 23 OVUM ASPIRATION PUMPS MARKET, BY END USER,
2019–2026 (USD MILLION) 81
6.2.4 MICROMANIPULATOR SYSTEMS 81
6.2.4.1 Growing demand due to rising infertility rates 81
TABLE 24 MICROMANIPULATOR SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 82
TABLE 25 MICROMANIPULATOR SYSTEMS MARKET, BY CYCLE,
2019–2026 (USD MILLION) 82
TABLE 26 MICROMANIPULATOR SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
TABLE 27 MICROMANIPULATOR SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION) 83
6.2.4.2 Technological advancements drive market growth 83
TABLE 28 INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 84
TABLE 29 INCUBATORS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 84
TABLE 30 INCUBATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 31 INCUBATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 85
6.2.5 GAS ANALYZERS 86
6.2.5.1 Increasing use of incubators in IVF labs to drive demand 86
TABLE 32 GAS ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 33 GAS ANALYZERS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 86
TABLE 34 GAS ANALYZERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 87
TABLE 35 GAS ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION) 87
6.2.6 LASER SYSTEMS 88
6.2.6.1 Multiple applications boost demand 88
TABLE 36 LASER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 88
TABLE 37 LASER SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 89
TABLE 38 LASER SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 89
TABLE 39 LASER SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 90
6.2.7 CRYOSYSTEMS 90
6.2.7.1 High demand due to growing desire among women to
extend childbearing years 90
TABLE 40 CRYOSYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 90
TABLE 41 CRYOSYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 91
TABLE 42 CRYOSYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 91
TABLE 43 CRYOSYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 91
6.2.8 CABINETS 92
6.2.8.1 Offer high levels of protection during IVF procedures 92
TABLE 44 CABINETS MARKET, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 45 CABINETS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 92
TABLE 46 CABINETS MARKET, BY TYPE, 2019–2026 (USD MILLION) 93
TABLE 47 CABINETS MARKET, BY END USER, 2019–2026 (USD MILLION) 93
6.2.9 ANTI-VIBRATION TABLES 93
6.2.9.1 Ergonomic design offers ease during IVF procedure 93
TABLE 48 ANTI-VIBRATION TABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 94
TABLE 49 ANTI-VIBRATION TABLES MARKET, BY CYCLE, 2019–2026 (USD MILLION) 94
TABLE 50 ANTI-VIBRATION TABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 51 ANTI-VIBRATION TABLES MARKET, BY END USER,
2019–2026 (USD MILLION) 95
6.2.10 WITNESS SYSTEMS 95
6.2.10.1 Growing demand due to ability to reduce human error 95
TABLE 52 WITNESS SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 96
TABLE 53 WITNESS SYSTEMS MARKET, BY CYCLE, 2019–2026 (USD MILLION) 96
TABLE 54 WITNESS SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 55 WITNESS SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 97
6.2.11 ACCESSORIES 97
TABLE 56 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 98
TABLE 57 ACCESSORIES MARKET, BY CYCLE, 2019–2026 (USD MILLION) 98
TABLE 58 ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 99
TABLE 59 ACCESSORIES MARKET, BY END USER, 2019–2026 (USD MILLION) 99
6.3 REAGENTS & MEDIA 99
TABLE 60 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 61 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY CYCLE,
2019–2026 (USD MILLION) 100
TABLE 62 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 63 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION) 101
TABLE 64 IN VITRO FERTILIZATION REAGENTS AND MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 102
6.3.1 EMBRYO CULTURE MEDIA 102
6.3.1.1 Help improve embryo during development phase 102
TABLE 65 EMBRYO CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 102
TABLE 66 EMBRYO CULTURE MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION) 103
TABLE 67 EMBRYO CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 68 EMBRYO CULTURE MEDIA MARKET, BY END USER,
2019–2026 (USD MILLION) 103
6.3.2 CRYOPRESERVATION MEDIA 104
6.3.2.1 Offers preservation of embryo, resulting in potential fertility 104
TABLE 69 CRYOPRESERVATION MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 104
TABLE 70 CRYOPRESERVATION MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION) 104
TABLE 71 CRYOPRESERVATION MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 72 CRYOPRESERVATION MEDIA MARKET, BY END USER,
2019–2026 (USD MILLION) 105
6.3.3 SPERM PROCESSING MEDIA 105
6.3.3.1 Growing number of IVF procedure using donor sperms to fuel the demand of sperm processing media 105
TABLE 73 SPERM PROCESSING MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 106
TABLE 74 SPERM PROCESSING MEDIA MARKET, BY CYCLE,
2019–2026 (USD MILLION) 106
TABLE 75 SPERM PROCESSING MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 76 SPERM PROCESSING MEDIA MARKET, BY END USER,
2019–2026 (USD MILLION) 107
6.3.4 OVUM PROCESSING MEDIA 108
6.3.4.1 Prevents oocytes from ice crystal formation,
forming long term storage 108
TABLE 77 OVUM PROCESSING MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 108
TABLE 78 OVUM PROCESSING MEDIA MARKET, BY CYCLE, 2019–2026 (USD MILLION) 108
TABLE 79 OVUM PROCESSING MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 80 OVUM PROCESSING MEDIA MARKET, BY END USER,
2019–2026 (USD MILLION) 109
7 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE 110
7.1 INTRODUCTION 111
TABLE 81 COMPARISON BETWEEN FRESH AND FROZEN EGG CYCLES 111
TABLE 82 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,
2019–2026 (USD MILLION) 111
7.2 FRESH NON-DONOR 112
7.2.1 INCREASE EFFECTIVENESS OF FRESH NON DONOR CYCLE TO
INCREASE ITS ADOPTION 112
TABLE 83 FRESH NON-DONOR MARKET, BY REGION, 2019–2026 (USD MILLION) 112
7.3 FROZEN NON-DONOR 112
7.3.1 BENEFITS OFFERED SUCH AS LONG-TERM STORAGE OF FROZEN EGGS
TO ACCELERATE THE GROWTH OF FROZEN-NON DONOR CYCLE 112
TABLE 84 FROZEN NON-DONOR MARKET, BY REGION, 2019–2026 (USD MILLION) 113
7.4 FROZEN DONOR 113
7.4.1 INCREASED AFFORDABILITY, AND EASE OF IMPLANTATION OF FROZEN DONOR CYCLE PROCESS TO SUPPORT THE GROWTH 113
TABLE 85 FROZEN DONOR MARKET, BY REGION, 2019–2026 (USD MILLION) 114
7.5 FRESH DONOR 114
7.5.1 INCREASED CHANCES OF HAVING ADDITIONAL EMBRYOS FROZEN THROUGH THIS CYCLE TO BOOST ITS ADOPTION 114
TABLE 86 FRESH DONOR MARKET, BY REGION, 2019–2026 (USD MILLION) 114
8 IN VITRO FERTILIZATION MARKET, BY TYPE 115
8.1 INTRODUCTION 116
TABLE 87 IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 116
8.2 CONVENTIONAL IVF 116
8.2.1 DECLINING FEMALE FERTILITY TO INCREASE THE PRACTICE OF CONVENTIONAL IVF METHOD. 116
TABLE 88 CONVENTIONAL IVF MARKET, BY REGION, 2019–2026 (USD MILLION) 117
8.3 IVF WITH ICSI 117
8.3.1 GROWING AWARENESS ABOUT THE HIGHER SUCCESS RATE OF IVF OFFERED TO BOOST THE GROWTH OF IVF WITH ICSI PROCEDURE 117
TABLE 89 IVF WITH ICSI MARKET, BY REGION, 2019–2026 (USD MILLION) 117
8.4 IVF WITH DONOR EGGS 118
8.4.1 USE OF DONOR EGGS DURING IVF CYCLE HAS RESULTED IN INCREASED CHANCES OF PREGNANCY, BOOSTING ITS GROWTH 118
TABLE 90 IVF WITH DONOR EGGS MARKET, BY REGION, 2019–2026 (USD MILLION) 118
8.5 OTHERS 119
8.5.1 INTRODUCTION OF NEW IVF DEVICES TO SUPPORT THE GROWTH
OTHER SEGMENT 119
TABLE 91 OTHERS MARKET, BY REGION, 2019–2026 (USD MILLION) 119
9 IN VITRO FERTILIZATION MARKET, BY END USER 120
9.1 INTRODUCTION 121
TABLE 92 IN VITRO FERTILIZATION MARKET, BY END USER, 2019–2026 (USD MILLION) 121
9.2 FERTILITY CLINICS 121
9.2.1 GROWING NUMBER OF IVF CLINICS WORLDWIDE DRIVE SEGMENT GROWTH 121
TABLE 93 IN VITRO FERTILIZATION MARKET FOR FERTILITY CLINICS, BY REGION,
2019–2026 (USD MILLION) 122
9.3 HOSPITALS AND SURGICAL CENTERS 122
9.3.1 GOVERNMENT INITIATIVES TO INCREASE NUMBER OF HOSPITALS EQUIPPED TO PERFORM IVF PROCEDURES CONTRIBUTE TO MARKET GROWTH 122
TABLE 94 IN VITRO FERTILIZATION MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION) 123
9.4 RESEARCH INSTITUTES 123
9.4.1 IMPROVED CLINICAL EFFICACY OF IVF OPTIONS AIDS MARKET GROWTH 123
TABLE 95 IN VITRO FERTILIZATION MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 124
9.5 CRYOBANKS 125
9.5.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS DRIVE DEMAND FOR CRYOBANKS 125
TABLE 96 IN VITRO FERTILIZATION MARKET FOR CRYOBANKS, BY REGION,
2019–2026 (USD MILLION) 125
10 IN VITRO FERTILIZATION MARKET, BY REGION 126
10.1 INTRODUCTION 127
TABLE 97 IN VITRO FERTILIZATION MARKET, BY REGION, 2019–2026 (USD MILLION) 127
10.2 ASIA PACIFIC 127
FIGURE 29 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET SNAPSHOT 128
TABLE 98 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 99 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 129
TABLE 100 ASIA PACIFIC: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 101 ASIA PACIFIC: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET,
BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 102 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 103 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,
2019–2026 (USD MILLION) 132
TABLE 104 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY END USER,
2019–2026 (USD MILLION) 132
10.2.1 CHINA 133
10.2.1.1 Declining birth rate to drive demand for IVF procedures 133
TABLE 105 CHINA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 133
TABLE 106 CHINA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 107 CHINA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION) 134
10.2.2 JAPAN 135
10.2.2.1 Growing awareness to boost adoption of IVF procedures 135
TABLE 108 JAPAN: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 135
TABLE 109 JAPAN: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 110 JAPAN: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
10.2.3 INDIA 137
10.2.3.1 Rising medical tourism to offer high-growth opportunities
for IVF market players 137
TABLE 111 INDIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 137
TABLE 112 INDIA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 113 INDIA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION) 138
10.2.4 AUSTRALIA 139
10.2.4.1 Government initiatives to support market growth 139
TABLE 114 AUSTRALIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 139
TABLE 115 AUSTRALIA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 116 AUSTRALIA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION) 140
10.2.5 SOUTH KOREA 141
10.2.5.1 Rising R&D activities to positively impact market growth 141
TABLE 117 SOUTH KOREA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 141
TABLE 118 SOUTH KOREA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 119 SOUTH KOREA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET,
BY TYPE, 2019–2026 (USD MILLION) 142
10.2.6 REST OF ASIA PACIFIC 143
TABLE 120 ROAPAC: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 121 ROAPAC: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 122 ROAPAC: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
10.3 EUROPE 145
TABLE 123 EUROPE: IN VITRO FERTILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 124 EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 146
TABLE 125 EUROPE: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 126 EUROPE: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 127 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 128 EUROPE: IN VITRO FERTILIZATION MARKET, BY CYCLE,
2019–2026 (USD MILLION) 148
TABLE 129 EUROPE: IN VITRO FERTILIZATION MARKET, BY END USER,
2019–2026 (USD MILLION) 148
10.3.1 GERMANY 148
10.3.1.1 Favorable funding scenario for IVF treatments to drive market growth 148
TABLE 130 GERMANY: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 149
TABLE 131 GERMANY: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 132 GERMANY: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET,
BY TYPE, 2019–2026 (USD MILLION) 150
10.3.2 UK 151
10.3.2.1 Supportive regulatory framework to enhance market growth 151
FIGURE 30 UK: NUMBER OF IVF CYCLES, BY EGG AND SPERM SOURCE, 2010-2019 151
TABLE 133 UK: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 152
TABLE 134 UK: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 135 UK: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
10.3.3 FRANCE 153
10.3.3.1 Rising healthcare spending to drive market growth 153
TABLE 136 FRANCE: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 137 FRANCE: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 138 FRANCE: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET ,
BY TYPE, 2019–2026 (USD MILLION) 155
10.3.4 ITALY 155
10.3.4.1 Decreasing fertility rates to drive demand for IVF procedures 155
TABLE 139 ITALY: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 140 ITALY: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 141 ITALY: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
10.3.5 SPAIN 157
10.3.5.1 Increasing fertility tourism to boost market 157
TABLE 142 SPAIN: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 157
TABLE 143 SPAIN: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 144 SPAIN: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE, 2019–2026 (USD MILLION) 158
10.3.6 REST OF EUROPE 159
TABLE 145 ROE: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 146 ROE: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 147 ROE: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET , BY TYPE,
2019–2026 (USD MILLION) 160
10.4 NORTH AMERICA 161
TABLE 148 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 161
TABLE 149 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 161
TABLE 150 NORTH AMERICA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 151 NORTH AMERICA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET ,
BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 152 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 153 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2019–2026 (USD MILLION) 163
TABLE 154 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER,
2019–2026 (USD MILLION) 164
10.4.1 US 164
10.4.1.1 Increasing healthcare expenditure drives IVF market 164
TABLE 155 US: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 165
TABLE 156 US: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 157 US: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
10.4.2 CANADA 167
10.4.2.1 High cost of in vitro fertilization to restrain market growth 167
TABLE 158 CANADA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 167
TABLE 159 CANADA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 160 CANADA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET,
BY TYPE, 2019–2026 (USD MILLION) 168
10.5 LATIN AMERICA 169
TABLE 161 LATAM: IN VITRO FERTILIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 169
TABLE 162 LATAM: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 163 LATAM: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 164 LATAM: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 165 LATAM: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 166 LATAM: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,
2019–2026 (USD MILLION) 171
TABLE 167 LATAM: IN VITRO FERTILIZATION MARKET, BY END USER,
2019–2026 (USD MILLION) 171
10.5.1 BRAZIL 172
10.5.1.1 Supportive government regulations drive market 172
TABLE 168 BRAZIL: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 172
TABLE 169 BRAZIL: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 170 BRAZIL: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 171 MEXICO: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 174
TABLE 172 MEXICO: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 173 MEXICO: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
10.5.2 REST OF LATIN AMERICA 176
TABLE 174 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 176
TABLE 175 REST OF LATIN AMERICA: IN VITRO FERTILIZATION EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 176 REST OF LATIN AMERICA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
10.6 MIDDLE EAST & AFRICA 178
10.6.1 RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 178
TABLE 177 MEA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 178
TABLE 178 MEA: IN VITRO FERTILIZATION EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 179 MEA: IN VITRO FERTILIZATION REAGENTS & MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 180 MEA: IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 181 MEA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,
2019–2026 (USD MILLION) 180
TABLE 182 MEA: IN VITRO FERTILIZATION MARKET, BY END USER,
2019–2026 (USD MILLION) 181
11 COMPETITIVE LANDSCAPE 182
11.1 OVERVIEW 182
11.2 KEY PLAYER STRATEGIES 182
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 183
FIGURE 31 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN IN VITRO
FERTILIZATION MARKET 183
11.4 MARKET SHARE ANALYSIS (2020) 183
TABLE 183 IN VITRO FERTILIZATION MARKET: DEGREE OF COMPETITION 183
11.5 COMPETITIVE LEADERSHIP MAPPING 185
11.5.1 STARS 185
11.5.2 PERVASIVE PLAYERS 185
11.5.3 EMERGING LEADERS 185
11.5.4 PARTICIPANTS 185
FIGURE 32 IN VITRO FERTILIZATION MARKET: COMPETITIVE LEADERSHIP
MAPPING, 2020 186
11.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020) 187
11.6.1 PROGRESSIVE COMPANIES 187
11.6.2 STARTING BLOCKS 187
11.6.3 RESPONSIVE COMPANIES 187
11.6.4 DYNAMIC COMPANIES 187
FIGURE 33 IN VITRO FERTILIZATION MARKET: COMPETITIVE LEADERSHIP MAPPING
FOR START-UPS/SMES, 2020 188
11.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN IN VITRO FERTILIZATION MARKET 189
11.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
IN IN VITRO FERTILIZATION MARKET 189
TABLE 184 PRODUCT FOOTPRINT OF COMPANIES 190
TABLE 185 REGIONAL FOOTPRINT OF COMPANIES 191
11.8 COMPETITIVE SCENARIO 192
11.8.1 IN VITRO FERTILIZATION MARKET: PRODUCT LAUNCHES AND
REGULATORY APPROVALS 192
TABLE 186 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS,
JANUARY 2018–AUGUST 2021 192
11.8.2 IN VITRO FERTILIZATION MARKET: DEALS 192
TABLE 187 KEY DEALS, JANUARY 2018–AUGUST 2021 192
11.8.3 IN VITRO FERTILIZATION MARKET: OTHER DEVELOPMENTS 193
TABLE 188 OTHER KEY DEVELOPMENTS, JANUARY 2018–AUGUST 2021 193
12 COMPANY PROFILES 194
12.1 MAJOR COMPANIES 194
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1.1 THE COOPER COMPANIES INC. 194
TABLE 189 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW 194
FIGURE 34 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020) 195
TABLE 190 THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS 195
12.1.2 COOK GROUP 199
TABLE 191 COOK GROUP: BUSINESS OVERVIEW 199
TABLE 192 COOK GROUP: PRODUCT OFFERINGS 199
12.1.3 VITROLIFE 201
TABLE 193 VITROLIFE: BUSINESS OVERVIEW 201
FIGURE 35 VITROLIFE: COMPANY SNAPSHOT (2020) 202
TABLE 194 VITROLIFE: PRODUCT OFFERINGS 202
12.1.4 THERMO FISHER SCIENTIFIC 205
TABLE 195 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 205
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 206
TABLE 196 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 206
12.1.5 HAMILTON THORNE LTD. 208
TABLE 197 HAMILTON THORNE LTD.: BUSINESS OVERVIEW 208
FIGURE 37 HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020) 208
TABLE 198 HAMILTON THORNE LTD.: PRODUCT OFFERINGS 209
12.1.6 ESCO MICRO PTE. LTD. 211
TABLE 199 ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW 211
TABLE 200 ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS 211
12.1.7 GENEA LIMITED 213
TABLE 201 GENEA LIMITED: BUSINESS OVERVIEW 213
TABLE 202 GENEA LIMITED: PRODUCT OFFERINGS 213
12.1.8 IVFTECH APS 215
TABLE 203 IVFTECH APS: BUSINESS OVERVIEW 215
TABLE 204 IVFTECH APS: PRODUCT OFFERINGS 215
12.1.9 FUJIFILM IRVINE SCIENTIFIC 216
TABLE 205 FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW 216
FIGURE 38 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020) 217
TABLE 206 FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS 218
12.1.10 THE BAKER COMPANY, INC. 220
TABLE 207 THE BAKER COMPANY, INC.: BUSINESS OVERVIEW 220
TABLE 208 THE BAKER COMPANY, INC.: PRODUCTS OFFERED 220
12.1.11 KITAZATO CORPORATION 221
TABLE 209 KITAZATO CORPORATION: BUSINESS OVERVIEW 221
TABLE 210 KITAZATO CORPORATION: PRODUCTS OFFERED 221
12.1.12 CORNING INCORPORATED 223
TABLE 211 THE CORNING INCORPORATED.: BUSINESS OVERVIEW 223
FIGURE 39 CORNNG INCORPORTAED: COMPANY SNAPSHOT (2020) 224
TABLE 212 CORNING INCORPORATED.: PRODUCT OFFERINGS 225
12.1.13 ZEISS GROUP 226
TABLE 213 ZEISS GROUP: BUSINESS OVERVIEW 226
FIGURE 40 ZEISS GROUP: COMPANY SNAPSHOT (2020) 226
TABLE 214 ZEISS GROUP: PRODUCT OFFERINGS 227
12.1.14 FERTIPRO NV 228
TABLE 215 FERTIPRO NV : BUSINESS OVERVIEW 228
TABLE 216 FERTIPRO NV: PRODUCT OFFERINGS 228
12.1.15 EPPENDORF 229
TABLE 217 EPPENDORF.: BUSINESS OVERVIEW 229
FIGURE 41 EPPENDORF: COMPANY SNAPSHOT (2020) 229
TABLE 218 EPPENDORF.: PRODUCT OFFERINGS 230
12.2 OTHER COMPANIES 231
12.2.1 DXNOW, INC. 231
12.2.2 NIDACON INTERNATIONAL AB 231
12.2.3 MICROTECH IVF S.R.O. 232
12.2.4 SAR HEALTHLINE PVT. LTD. 232
12.2.5 INVITROCARE INC. 233
*Details on Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 234
13.1 DISCUSSION GUIDE 234
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 238
13.3 AVAILABLE CUSTOMIZATIONS 240
13.4 RELATED REPORTS 240
13.5 RELATED REPORTS 241
